Ardigen at BIO-Europe in Copenhagen

Topic:

This year, Ardigen’s team once again participated in BIO-Europe Conference in Copenhagen. The Europe’s largest biotechnology conference was represented by 61 countries and brought together over 4000 participants. Over the three days of the conference our representatives Karolina Tkaczuk and Piotr Stepniak took part in number of very engaging one to one meetings, panel discussion, company presentations as well as networking sessions. Especially interesting developments were presented by companies in cell therapy and vaccine design space. It is becoming a highly competitive field where time to delivery of personalized treatment, costs of the process and quality of the induced adaptive immune response make the leaders. You could meet Karolina and Piotr during the partnering sessions and at the Polish Investment and Trade Agency (PAIH) booth. We look forward to the next edition that will be held in Hamburg. photo: Representatives of PAIH, Selvita , OncoArendi and Ardigen at Bio-Europe 2018.

You might be also interested in:

Illustration of agentic AI in drug discovery connecting computational analysis with laboratory experiments.
How Agentic AI is closing the loop in drug discovery
Ardigen phenAID platform
AI Phenotypic Profiling for Hit Prioritization
biology binder design case study
AI Protein Binder Design Case Study
scientist working on the target identification case study
AI Target Discovery from Multimodal Data

Contact

Ready to transform drug discovery?

Discover how one of the top AI CROs in the world, can be your trusted partner in revolutionizing drug discovery through AI.

Contact us today to learn more about our tailored solutions for empowering your drug development journey.

Send us a message and we will contact you back within 48 hours.

Newsletter

Become an insider

Be the first to know about Ardigen’s latest news and get access to our publications, webinars and more!